Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells
Michael G. Kharas(Memorial Sloan Kettering Cancer Center), Vanessa M. Scarfone, Zachary A. Knight(Howard Hughes Medical Institute), Matthew R. Janes(University of California, Irvine), Kevan M. Shokat(Howard Hughes Medical Institute), Michael B. Lilly(Medical University of South Carolina)
Cited by 150
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k